Table 1 Descriptive data of PsA patients

PSA

Age (years)

Range

20

–

70

Mean ± SD

44.750

 ± 

12.187

DD (years)

Range

1

–

25

Mean ± SD

10.750

 ± 

6.316

N

%

Sex

Male

22

36.67

Female

38

63.33

WBCS

Range

3.6

–

13.3

Mean ± SD

6.558

 ± 

2.131

Neutrophils

Range

1.9

–

8.9

Mean ± SD

4.148

 ± 

1.580

Lymphocytes

Range

0.8

–

3.25

Mean ± SD

1.993

 ± 

0.600

HCT

Range

34

–

40.1

Mean ± SD

37.088

 ± 

1.567

RBCs

Range

4.2

–

6.2

Mean ± SD

4.793

 ± 

0.532

Hb

Range

11.4

–

15.2

Mean ± SD

12.600

 ± 

1.102

MCV

Range

64

–

100

Mean ± SD

80.235

 ± 

7.156

MCH

Range

12.7

–

30.3

Mean ± SD

24.933

 ± 

3.973

RDW%

Range

11.1

–

18.3

Mean ± SD

13.655

 ± 

2.015

PLT

Range

145

–

410

Mean ± SD

247.833

 ± 

72.786

MPV/fl

Range

7.1

–

12

Mean ± SD

8.675

 ± 

1.027

PDW

Range

7.9

–

18.8

Mean ± SD

11.945

 ± 

2.513

Hb/PLT ratio

Range

0.03

–

0.1

Mean ± SD

0.055

 ± 

0.017

RDW%/PLT ratio

Range

0.03

–

0.11

Mean ± SD

0.059

 ± 

0.018

RBCs/PLT ratio

Range

0.01

–

0.03

Mean ± SD

0.021

 ± 

0.006

Hb/RDW% ratio

Range

0.63

–

1.28

Mean ± SD

0.941

 ± 

0.153

Neutrophil/lymphocyte ratio

Range

1.36

–

3

Mean ± SD

2.091

 ± 

0.491

PLT/lymphocyte ratio

Range

60.42

–

300.77

Mean ± SD

133.302

 ± 

48.824

ESR

Range

8

–

180

Mean ± SD

60.475

 ± 

37.728

CRP

Range

2

–

42

Mean ± SD

14.667

 ± 

7.097

HLA B27

Positive

43

71.67

Negative

17

28.33

SSZ

Yes

35

58.33

No

25

41.67

CS

Yes

10

16.67

No

50

83.33

MTX

Yes

47

78.33

No

13

21.67

Biologics

No

20

33.33

Golimumab

12

20.00

Secukinumab

18

30.00

Adalimumab-atto

10

16.67

Biologics

Non-biologics

20

33.33

Biologics

40

66.67

Duration biologics (months)

Range

3

–

24

Mean ± SD

8.100

 ± 

4.361